GO
Loading...

Gilead Sciences Inc

More

  • Final Glance: Biotechnology companies Wednesday, 29 Oct 2014 | 6:02 PM ET

    Amgen Inc. rose $1.69 or 1.1 percent, to $158.88. Biogen Idec fell $2.97 or. 9 percent, to $315.06. Celgene Corp. fell$. 56 or. 5 percent, to $105.14.

  • Midday Glance: Biotechnology companies Wednesday, 29 Oct 2014 | 1:41 PM ET

    Amgen Inc. rose $1.86 or 1.2 percent, to $159.05. Biogen Idec fell $3.36 or 1.1 percent, to $314.67. Celgene Corp. fell$. 67 or. 6 percent, to $105.03.

  • Most active Nasdaq-traded stocks Wednesday, 29 Oct 2014 | 1:41 PM ET

    American Realty Capital Properties Inc. fell 19.2 percent to $10.00 with 210,299,000 shares traded. Apple Inc. rose. 6 percent to $107.34 with 49,534,400 shares traded. DryShips Inc. fell 8.7 percent to $1.47 with 27,831,800 shares traded.

  • Early Glance: Biotechnology companies Wednesday, 29 Oct 2014 | 10:53 AM ET

    Amgen Inc. rose$. 90 or. 6 percent, to $158.09. Biogen Idec rose $1.09 or. 3 percent, to $319.12. Celgene Corp. rose$. 43 or. 4 percent, to $106.13.

  • Final Glance: Biotechnology companies Tuesday, 28 Oct 2014 | 6:14 PM ET

    Amgen Inc. rose $8.99 or 6.1 percent, to $157.19. Biogen Idec fell $1.95 or. 6 percent, to $318.03. Celgene Corp. rose $2.60 or 2.5 percent, to $105.70.

  • Gilead beats Street 3Q forecasts Tuesday, 28 Oct 2014 | 4:21 PM ET

    FOSTER CITY, Calif.— FOSTER CITY, Calif.— Gilead Sciences Inc. on Tuesday reported third-quarter profit of $2.73 billion. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of $1.80 per share. Analysts expected $5.88 billion, according to Zacks.

  • Midday Glance: Biotechnology companies Tuesday, 28 Oct 2014 | 1:25 PM ET

    Amgen Inc. rose $7.24 or 4.9 percent, to $155.44. Biogen Idec fell $3.28 or 1.0 percent, to $316.70. Celgene Corp. rose $2.18 or 2.1 percent, to $105.28.

  • Early Glance: Biotechnology companies Tuesday, 28 Oct 2014 | 10:31 AM ET

    Amgen Inc. rose $6.60 or 4.5 percent, to $154.80. Biogen Idec fell $1.10 or. 3 percent, to $318.88. Celgene Corp. rose $2.18 or 2.1 percent, to $105.28.

  • Oil and earnings the main attractions (for now) Tuesday, 28 Oct 2014 | 5:54 AM ET
    Traders on the floor of the New York Stock Exchange, October 15, 2014.

    As markets await Fed's move to end the quantitative easing program when it releases its statement Wednesday, traders keep eyes on oil and earnings.

  • What traders are watching while they wait for the Fed Tuesday, 28 Oct 2014 | 5:38 AM ET
    Traders on the floor of the New York Stock Exchange, October 15, 2014.

    As markets await Fed's move to end the quantitative easing program when it releases its statement Wednesday, traders keep eyes on oil and earnings.

  • Cramer's secret oil strategy: Unlock profits Monday, 27 Oct 2014 | 6:12 PM ET
    Jim Cramer on Mad Money.

    Jim Cramer shares his tricks of the trade on how to benefit from the low price of oil, and how to pick the right stocks in a dazed and confused market

  • Final Glance: Biotechnology companies Monday, 27 Oct 2014 | 6:06 PM ET

    Amgen Inc. rose$. 94 or. 6 percent, to $148.20. Biogen Idec fell $1.69 or. 5 percent, to $319.98. Celgene Corp. fell$. 14 or. 1 percent, to $103.10.

  • NEW YORK, Oct 27- U.S. stocks edged lower in afternoon trading on Monday, pausing after the S&P 500' s biggest weekly gain since January 2013, as energy shares fell with another decline in oil prices. Shares of Gilead Sciences, due to report results Tuesday, were up 1.8 percent and helped to limit some of the declines. Micron Technology jumped 3.5 percent and was the...

  • What's boosting healthiest sector in S&P this year Monday, 27 Oct 2014 | 1:43 PM ET

    Health care has been on a tear in 2014, and there is still room for upside. Wall Street analysts are focusing on the following four trends.

  • Midday Glance: Biotechnology companies Monday, 27 Oct 2014 | 1:17 PM ET

    Amgen Inc. rose$. 57 or. 4 percent, to $147.83. Biogen Idec fell $2.92 or. 9 percent, to $318.75. Celgene Corp. fell$. 19 or. 2 percent, to $103.05.

  • Early Glance: Biotechnology companies Monday, 27 Oct 2014 | 10:40 AM ET

    Amgen Inc. fell$. 07 or percent, to $147.19. Biogen Idec fell $3.44 or 1.1 percent, to $318.23. Celgene Corp. fell$. 47 or. 5 percent, to $102.77.

  • Final Glance: Biotechnology companies Friday, 24 Oct 2014 | 6:35 PM ET

    Amgen Inc. rose$. 01 or percent, to $147.26. Biogen Idec rose $5.61 or 1.8 percent, to $321.67. Celgene Corp. rose $2.84 or 2.8 percent, to $103.24.

  • Cramer: Ebola, the Fed and earnings, oh my Friday, 24 Oct 2014 | 6:15 PM ET

    Can the bull market continue? In preparation for earnings season to continue next week, Jim Cramer gives his take on what to expect.

  • Oct 24- Amgen Inc, one of the world's largest biotechnology companies, will unveil next week its first strategy update since early 2013, but few expect a major shift like the split-up recently proposed by Daniel Loeb's Third Point hedge fund. In a letter to investors on Tuesday, Loeb said Amgen has "all the hallmarks of a hidden value situation" and should divide...

  • Midday Glance: Biotechnology companies Friday, 24 Oct 2014 | 1:17 PM ET

    Amgen Inc. fell $1.41 or 1.0 percent, to $145.84. Biogen Idec rose $3.09 or 1.0 percent, to $319.15. Celgene Corp. rose $2.15 or 2.1 percent, to $102.55.